Analyst Ratings for CymaBay Therapeutic (CBAY)

CBAY Rating Summary

  |   Expand Research on CBAY
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.9 / 10   Percentile Rank: 38%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/19/2024 Jones Trading Sean Kim Downgrade Hold
(Buy)
N/A
(N/A)
32.46
(32.48)
0.06% Details
2/20/2024 Leerink Partners Thomas J. Smith Downgrade Market Perform
(Outperform)
32.50
(26.00)
32.20
(32.48)
0.87% Details